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Abstract
Reverse genetics in the mosquito Anopheles gambiae by RNAi mediated gene silencing has led in recent years to an
advanced understanding of the mosquito immune response against infections with bacteria and malaria parasites. We
developed RNAi screens in An. gambiae hemocyte-like cells using a library of double-stranded RNAs targeting 109 genes
expressed highly or specifically in mosquito hemocytes to identify novel regulators of the hemocyte immune response.
Assays included phagocytosis of bacterial bioparticles, expression of the antimicrobial peptide CEC1, and basal and induced
expression of the mosquito complement factor LRIM1. A cell viability screen was also carried out to assess dsRNA
cytotoxicity and to identify genes involved in cell growth and survival. Our results identify 22 novel immune regulators,
including proteins putatively involved in phagosome assembly and maturation (Ca2+ channel, v-ATPase and cyclin-
dependent protein kinase), pattern recognition (fibrinogen-domain lectins and Nimrod), immune modulation (peptidase
and serine protease homolog), immune signaling (Eiger and LPS-induced factor), cell adhesion and communication (Laminin
B1 and Ninjurin) and immune homeostasis (Lipophorin receptor). The development of robust functional cell-based assays
paves the way for genome-wide functional screens to study the mosquito immune response to infections with human
pathogens.
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Introduction
Anopheles gambiae is a major vector of Plasmodium falciparum
malaria in sub-Saharan Africa and a secondary vector of other
parasitic and viral diseases [1]. Differences in vector susceptibility
to malaria parasites are partly attributed to the ability of the
mosquito immune system to fight infections. The developmental
migration of Plasmodium within the mosquito hemolymph, the
main carrier of the immune system, presents opportunities for the
vector humoral and cellular immune reactions to attack the
parasites [2]. Key functions of mosquito hemolymph components
include killing of Plasmodium ookinetes as soon as they emerge from
the midgut epithelium [3] and sporozoites before they invade the
salivary glands [4]. Numerous mosquito agonist and antagonist
effectors of Plasmodium and bacteria have been identified,
principally by RNAi-mediated reverse genetic tests using dsRNA
(double-stranded RNA) injections into adult mosquitoes [5]. These
factors operate in complex molecular networks that involve
pathogen recognition by secreted or membrane bound receptors,
activation of immune signaling pathways, and synthesis or
activation of effectors that contribute to lysis, melanization or
phagocytosis of the invading pathogens [2,6,7]. Importantly, many
of these factors are produced by hemocytes and function in the
hemolymph [8,9,10]. Two hemocyte expression datasets have
been reported recently, providing a comprehensive list of
hemocyte-expressed genes [8,11].
An. gambiae cell lines have been used extensively to study
mosquito immune responses [12,13,14,15]. Indeed, these cells are
capable of accomplishing complex immune tasks that include
phagocytosis of bacteria and beads [16], as well as expression of
immune factors upon microbial challenge. It has been shown that
IMD pathway activation in cell lines leads to robust expression of
the antimicrobial peptide (AMP) gene Cecropin 1 (CEC1) [15] and
other immune factors [13]. This pathway is activated when the
transmembrane receptor PGRPLC binds peptidoglycan (PGN)
and induces nuclear translocation of the REL2 transcription factor
[15,17,18].
The development of high-throughput RNAi screens in cultured
cells has been a major breakthrough in functional genomics of
model organisms, in both basic and applied research
[19,20,21,22]. Here we report the development and implementa-
tion of RNAi screens in An. gambiae cells to provide insights into the
functional immune repertoire of mosquito circulating hemocytes.
We have generated a dsRNA library targeting 109 genes
specifically or predominantly expressed in circulating hemocytes
and then optimized cell-based RNAi screens to investigate the role
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of these genes in phagocytosis of bacteria and transcriptional
activation of immune-related genes. Our results identify novel
regulators of the hemocyte immune responses and interactions
with pathogens, including regulators of a complement-like
pathway component that plays a key role in reactions to malaria
parasites. This is a key milestone towards development of genome-
wide RNAi screens in An. gambiae cells.
Results/Discussion
A hemocyte-specific dsRNA library
We generated a set of 111 dsRNAs to target 109 genes that
exhibit enriched expression in hemocytes, differential regulation
by immune challenges, and presence of immune-related InterPro
domains and/or signal peptide or transmembrane domains
(Dataset S1). To populate and annotate this dsRNA library we
used: two published datasets of genome-wide transcriptional
repertoires of An. gambiae circulating hemocytes from naive or
Plasmodium infected adult females [8,11], the published expression
profile of An. gambiae hemocyte-like cell lines in response to
microbial challenges [13], the VectorBase An. gambiae genome
annotation [23] and information about the silencing phenotypes of
Drosophila orthologs found in the GenomeRNAi database [24,25].
Analysis of AMP expression and dsRNA-mediated RNAi efficien-
cy (Text S1) led us to choose the Sua5.1* cell line [12,16,26] as our
model experimental system.
Cell growth and viability
We carried out viability screens to assess the levels of dsRNA
toxicity as determined by the effect of gene silencing on
fundamental housekeeping processes such as cell growth, prolif-
eration and survival, which could hamper true identification of
immune regulators. An. gambiae homologs of three genes previously
shown to cause lethal or growth-defective RNAi phenotypes in
Drosophila cells [22,27] were used as controls: inhibitor of apoptosis
1 (IAP1; AGAP007294), a ubiquitin-like/ribosomal fusion protein
(AGAP008001; 2 different dsRNA fragments) and the Rho1 small
GTPase (AGAP005160) (Table S2 and Text S1).
Two protocols were implemented to assess cell growth and
viability: (a) image acquisition and quantification by automated
fluorescence microscopy, which is time-consuming and technically
challenging but allows for more accurate and informative analysis;
and (b) microplate reader fluorescence quantification, which is
quicker and can accommodate large datasets but is less user-
responsive.
A subset of 37 dsRNAs was screened by automated fluorescence
microscopy. Staining cells with Sytox green/Hoechst was used to
assess the effect of dsRNAs on cell viability. Protocols in Volocity
Improvision and ImageJ softwares were developed to capture
images and quantify fluorescent cells, to determine the ratio of
dead cells (Sytox green positive) over the entire cell population
(Hoechst positive) (Figure 1A and Materials and Methods).
ANOVA statistics followed by Bonferroni’s post-test correction
revealed that dsIAP1 leads to a significant increase of cell
mortality. Silencing Rho1 significantly reduced the number of cells
but did not increase cell mortality (Figure S1, Figure S2 and Text
S1). The cells and their nuclei were much larger in size indicating
a defect in cytokinesis and cell cycle progression. A similar
phenotype was observed in Drosophila S2 cells after silencing the
orthologous Rho1 gene [22,27].
Next, we screened the entire collection of 111 dsRNAs using
plate reader quantification in conjunction with a CellTiter-Blue
Cell Viability assay. Data from three replicates were analyzed and
z-score analysis was performed posing thresholds of +/22 for at
least two replicates out of three. Reproducibility among replicates
was evaluated by correlation tests as shown in the plots in Figure
S3. Silencing the ubiquitin-like/ribosomal fusion protein gene
AGAP008001 led to significant decrease in cell viability (Figure 1B
and Figure S3). No other dsRNA treatment resulted in statistically
Figure 1. Cell growth and viability screen. (A) A fraction of the
dsRNA hemocyte-specific library was screened twice by automated
fluorescence microscopy. Fluorescent cells were automatically counted
using protocols developed in Volocity Improvision and ImageJ
software, as described in Materials and Methods. The ratios of dead
cells (Sytox Green positive) over the total number of cells (Hoechst
positive), and the standard deviation of replicates, are shown. (B) The
entire dsRNA collection was screened using the Cell Titer Blue/Plate
Reader method. The plot shows the z-score analysis of one
representative set of experiments. A z-score threshold of at least 2
was chosen, and positive hits are shown as open circles. No dsRNA-
treated samples and samples treated with 100 mM H2O2 are also
indicated. Three biological replicates were performed.
doi:10.1371/journal.ppat.1003145.g001
Author Summary
The mosquito immune system relies on innate humoral
and cellular reactions to fight infections, including those
by malaria parasites that must pass through mosquitoes
before they can infect humans. Therefore, a detailed
molecular understanding of these reactions could assist
the design of new ways to control the spread of malaria
and other mosquito-borne diseases. Here we use a
technique to silence in mosquito cultured cells genes that
are highly and/or specifically expressed in mosquito
hemocytes, the equivalent of human white blood cells,
as a means to investigate their function in reactions of the
mosquito immune system. Our study identifies several
novel regulators of immune reactions including phagocy-
tosis, the engulfment and subsequent destruction of
bacteria and other pathogens by hemocytes, the produc-
tion of antimicrobial peptides, which directly kill or inhibit
the proliferation of microbes, and the basal and induced
production of an important complement regulator. Com-
plement is a robust reaction of mosquitoes against malaria
parasites and bacteria through phagocytosis, lysis or
melanization (the enclosure of pathogens in a melanin
capsule). We also reveal intriguing molecular connections
between these reactions such as phagocytosis and
regulation of complement. Our study provides novel
insights into mosquito immune system and its reactions
against infections.
Novel Regulators of Mosquito Innate Immunity
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significant deviation from the average cell count. A general
observation was that dsRNA treatment resulted in significant cell
mortality that was independent of the targeted gene.
We validated the viability data in vivo by injecting dsRNAs of
control LacZ, IAP1 and AGAP008001 into newly emerged adult
female mosquitoes and then monitoring the survival of KD
mosquitoes daily (Figure S1). Both gene KDs led to statistically
significant increase of mortality rates compared to control. In
addition to the support that this analysis provided to our
experimental approach, the good correspondence between the ex
vivo cell-based viability screen and the in vivo phenotypic analysis
highlights opportunities for future use of such viability screens in
identifying targets of novel mosquito insecticides.
Bacterial phagocytosis screens
Phagocytosis is a highly effective and immediate response
against microbial invaders [28]. Mosquito hemocytes can bind and
phagocytose bacterial bioparticles and Sephadex beads, as well as
malaria sporozoites [4,29,30,31]. We established a fast and reliable
cell-based assay in An. gambiae cells using Escherichia coli bioparticles
conjugated with pHrodo succinimidyl ester, a pH-sensitive
fluorescent dye, to investigate the potential role of genes in the
hemocyte-enriched library in bacterial phagocytosis. The phago-
cytic activity of cells was determined as the increase of bioparticle
fluorescence caused by the drop of pH in the acidified phagosomes
[32].
Bacterial bioparticles were added to the cells three days after
incubation with dsRNA, and the capacity of cells to uptake
bioparticles was assessed by fluorescence measurements using a
microplate reader. Four time-points were assayed to take into
account the kinetics of bioparticle uptake (1, 3, 6 and 24 h post-
challenge). The measurements obtained were subtracted from
basal level measurements (0 h, immediately after challenge). The
entire dsRNA library was screened three times and z-score values
for each of the dsRNA in each of the replicate screens were
calculated. We considered positive dsRNA hits those with z-score
values above 2 or below 22 in at least two out of the three
replicates for each time point (Figure S4 and Supplemental Table
S3). Because our library is strongly biased towards genes that are
likely to play a role in immune reactions, the z-score method
which compares the effect of each dsRNA with the average effect
of all dsRNAs is a very strict condition. Therefore, we also
analysed the data using ANOVA followed by Tukey’s multiple
comparison test, thus comparing each dsRNA with the reference
dsLacZ control. The results from both methods revealed a total of
13 positive dsRNA hits, 6 from the z-score and 11 from ANOVA
(Table S3 and Figure 2A–B). Four dsRNAs showed significant
effects on bioparticle uptake with both methods: 2 of them
decreased phagocytosis (FBN8 and AGAP000095) and 2 of them
increased phagocytosis (AGAP006769 and FBN9). Cactus dsRNA
that was used as a positive control also led to a significant increase
in phagocytosis of E. coli as soon as 1 h after challenge, in
consistence with previous observations [29].
We examined the 13 positive hits from the microplate reader
analysis using automated fluorescence microscopy and a protocol
for quantification of phagocytosed bioparticles developed in the
ImageJ software. Bioparticle uptake was monitored 2 h and 20 h
after challenge and compared to the dsLacZ control using
ANOVA (Figure 2C–D). An overall consistency was observed
between the microplate reader and the microscopy analyses. Of
the 13 dsRNAs, 6 showed the expected phenotype with statistical
significance, 5 showed the expected phenotype but were not
statistically significant, and 2 showed no difference with the dsLacZ
control and/or a phenotype opposite to the expected, respectively
(Figure 2B). As mentioned earlier, imaging analysis can provide
additional, more detailed, information when compared to the
microplate reader method, but it is technically more challenging
and time consuming. The few discrepancies between these two
approaches may be due to both technical and biological reasons,
for example image analysis cannot quantify the amount of
bioparticles in a single cell, while the microplate reader quantifies
the intensity of fluorescence. Moreover, as shown in Figure 2D,
the distribution of fluorescent bioparticles is not uniform in the cell
layer, and this introduces another variable when microscope
images are captured and analyzed.
Next, we investigated the silencing effect of 8 out of the 13
dsRNAs identified by the microplate reader method on bacterial
phagocytosis in vivo. For this, we employed a protocol that was used
in an earlier study, in which bacteria injected into the mosquito
hemolymph spread rapidly into the cavity and are phagocytosed
by hemocytes often found in clusters associated with the tracheal
system [29]. We injected 2-day old mosquitoes with dsRNAs and 4
days later re-injected them with E. coli pHRodo-conjugated
bioparticles. Mosquitoes were dissected 1 h after bioparticle
injection, mounted onto glass slides and immediately observed
by fluorescence microscopy. Pictures of different parts of the
mosquito abdomens were captured and analyzed using a protocol
developed in ImageJ to quantify the numbers of fluorescent
particles (Figure 3). The results revealed strong in vivo phenotypes
similar to those of the cell-based analysis for 4 out of the 8
dsRNAs: AGAP000182, AGAP008492, AGAP004928 and
AGAP002243, the last one corroborated by a significant statistical
evaluation. Three dsRNAs (AGAP003879, FBN8 and
AGAP006769) also showed similar albeit weaker phenotypes
compared to the cell-based analysis and only one dsRNA
(AGAP009459) did not confirm the expected phenotype.
Novel regulators of phagocytosis
Based on to the microplate reader analysis, the silencing of 7
genes led to a significant decrease of the cellular capacity to
phagocytose E. coli bioparticles. Some of these genes were also
confirmed with the microscopy and the in vivo analysis, as
presented above. These genes encode: a protein of unknown
function with a putative signal peptide and a peptidase domain
(AGAP000182); a protein with a homodimerization BTB/POZ
domain, ankyrin repeats and a zinc finger domain (AGAP002243);
a putative transmembrane v-ATPase (AGAP003879); a membrane-
bound protein with a zinc finger and a LITAF (LPS-induced
tumor necrosis factor alpha factor) domain putatively involved in
immune signaling (AGAP004928) [33,34]; the fibrinogen-domain
FBN8 (also known as FREP57), previously shown to play a role in
anti-Plasmodium defense (AGAP011223) [35]; a putative Calcium
channel protein (AGAP000095); and a three-transmembrane
protein of unpredicted function (AGAP008500).
Two of these proteins are likely to play a role in phagosome
formation and maturation/acidification. The putative Ca2+
channel protein (AGAP000095) may be involved in the cellular
Ca2+ balance that is required for solubilization of the actin
meshwork surrounding nascent phagosomes, fusion of phagosomes
with granules containing lytic enzymes, or assembly and activation
of the superoxide-generating NADPH oxidase complex [36]. The
v-ATPase (AGAP003879) is known to play a role in phagosome
acidification in other model organisms [37]. Orthologs of
AGAP003879 and AGAP004928 in D. melanogaster show similar
phenotypes in RNAi screens that investigate host-pathogen
interactions (Dataset S1), as both KDs cause a decrease in
intracellular Listeria monocytogenes infection [38].
Novel Regulators of Mosquito Innate Immunity
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Figure 2. Bacterial phagocytosis screen. (A) Venn diagram showing the results of the z-score and ANOVA analyses of data obtained with the
microplate reader phagocytosis assay. (B) Heat map depicting the performance in the microscopy imaging and in vivo phagocytosis assays of the 13
dsRNAs identified as positive hits with the microplate reader assay. Dark green, significant decrease of phagocytosis; green, decrease of phagocytosis;
dark red, significant increase of phagocytosis; red, increase of phagocytosis; grey, similar to LacZ control; nd, not determined. (C) Microscopy imaging
analysis: phagocytosis rates of cells at 2 and 20 h following bioparticles challenge when genes identified as modulators of phagocytosis by
microplate reader assay are silenced. Data are shown as percent phagocytosis compared to dsLacZ-treated controls. (D) Examples of fluorescence
microscopy images of Sua5.1* cells treated with dsRNAs or Cytochalasin D. Images were captured 20 h after challenge with pHRodo bioparticles. The
graphs indicate the capacity of cells to uptake bioparticles following dsLacZ, dsCactus and Cytochalasin D treatments at 2 and 20 h after challenge, as
quantified by image analysis. Mean values of counted particles and standard errors are reported. Results from two experiments are shown. Asterisks
indicate statistically significant differences between each KD and the dsLacZ-treated controls (*: P,0,05; **: 0,005,P,0,05; ***: 0,0005,P,0,005).
doi:10.1371/journal.ppat.1003145.g002
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In contrast, silencing 6 out of the 109 genes leads to a significant
increase of E. coli phagocytosis. Proteins encoded by these genes
represent potential novel negative regulators of bacterial recogni-
tion and phagosome assembly. These include: a secreted protein of
unknown function that is strongly expressed in mosquito
hemocytes [8] and cultured cells following LPS or PGN challenge
(AGAP006769) [13]; a putative tyrosine and serine/threonine
kinase (AGAP009459) with homologs described in other mosqui-
toes (Aedes aegypti, AAEL008621, cell division protein kinase 1, cdk1;
and Culex quinquefasciatus, CPIJ001155, cdk2) and D. melanogaster
(CG5363, cdc2 cell division control protein); AGAP008492 that
does not exhibit similarity to any other genes and is regulated
during immune challenges [13]; the ortholog of Drosophila laminin
B1 chain (AGAP001381); and the fibrinogen-domain lectins
FBN30/FREP8 and FBN9/FREP13 (AGAP006914 and
AGAP011197, respectively) [35].
The negative effect of AGAP009459 silencing in bacterial
phagocytosis is possibly related to defects in cytoskeleton
regulation. Its Drosophila ortholog, cdc2, is similarly involved in
defense-related processes as highlighted by increased Listeria
intracellular infection, reduced Chlamydia infection and decreased
Drosophila C virus and influenza virus replication following
silencing [38,39,40]. Similarly, the fruit fly ortholog of Laminin
B1 may also play a role in innate immune reactions since its
silencing is shown to decrease viability after intestinal infections
with Serratia marcescens [41]. FBN9 has been previously shown to be
upregulated both by malaria parasite and E. coli infections [42].
The involvement of FBN9 in the defense against bacteria and
maintenance of basal immune homeostasis is supported by
evidence that the protein is found on the surface of non-challenged
cells and strongly co-localizes with bacteria as well as malaria
parasites following infection [35]. A specific role of FBN9 as a
negative regulator of phagocytosis can be therefore hypothesized
considering the fine interplay between different immune processes,
where a pattern recognition receptor may specifically promote one
in favor of another process.
Transcriptional activation of the AMP CEC1
It has been previously shown that the AMP CEC1 is
transcriptionally induced in cultured cells following immune
challenge and that this induction depends partly on the IMD
signaling pathway [13], triggered after PGN recognition by the
PGN Recognition Protein LC (PGRP-LC) [18]. To identify novel
hemocyte regulators of the A. gambiae IMD pathway and
potentially other pathways regulating the expression of AMPs,
we developed a luciferase reporter assay in Sua5.1* cells to screen
the hemocyte dsRNA library. A 660 bp fragment of the CEC1
promoter cloned upstream of the luciferase gene was used [15].
Initial experiments revealed a significant induction of CEC1
promoter activity 7 h after PGN challenge. A dsRNA targeting the
NF-kB transcription factor REL2, previously shown to regulate
CEC1 transcriptional activation [15], was included as a positive
control. Changes in luciferace activity were analyzed by calculat-
ing the z-score values of ratios of average RLU (Relative Light
Units) measurements of PGN vs. PBS treatments (Figure 4 and
Table S4). One-way ANOVA followed by Dunnet’s multiple-
comparison post-test was also performed to compare dsLacZ
control and KD values (Table S4).
Silencing AGAP010531 (FBN12 or FREP2) and AGAP006771 led
to increased CEC1 expression following PGN challenge.
AGAP006771 encodes a putative transmembrane protein ortholo-
gous to the Drosophila Tumor Necrosis Factor-like, eiger. Interest-
Figure 3. In vivo phagocytosis assay. (A) Pictures of abdominal
segments of adult female mosquitos injected with dsLacZ, dsA-
GAP004928 and dsAGAP008492 and then challenged with pHRodo E.
coli bioparticles. Fluorescence and brightfield images were captured
and hemocytes containing fluorescent bioparticles quantified. The
experiment was repeated twice with 8–10 mosquitoes per treatment.
Quantification of fluorescent bioparticles and statistical analysis were
performed as described in Materials and Methods. (B) The graph shows
the percentage of phagocytosis of the different KDs placing dsLacZ as
reference. Mean values and standard errors are reported. Asterisks
indicate statistical significance (**: 0,005,P,0,05) according to t-tests
applied to each gene KD compared to LacZKD.
doi:10.1371/journal.ppat.1003145.g003
Figure 4. Luciferase assays. (A) Transcriptional activation of CEC1
promoter upon PGN challenge. The graph reports the z-scores
calculated from the ratios of averaged RLU measurements after PGN
and PBS treatments. (B and C) Transcriptional regulation of LRIM1
promoter (B) upon PGN challenge (z-scores calculated from the ratios of
averaged RLU measurements after PGN and PBS treatments) and (C) in
basal conditions (z-scores calculated from the RLU measured after PBS
treatments). Positive hits are shown as open circles.
doi:10.1371/journal.ppat.1003145.g004
Novel Regulators of Mosquito Innate Immunity
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ingly, Drosophila eiger is also induced during microbial infections
and required for both resistance and tolerance to infections, partly
by controlling the expression of the AMP Diptericin [33,43]. Eiger
functions as a negative regulator of AMP expression following
PGN challenge and IMD pathway activation by blocking the
expression of the NF-kB factor, Relish (the ortholog of REL2),
through the JNK pathway [44]. Our data is consistent with the
fruit fly model and identify mosquito eiger as a negative regulator
of CEC1 expression. Like FBN9 that is identified as a negative
regulator of phagocytosis, FBN12 belongs to a family of putative
pattern recognition receptors known to be involved in immune
responses and maintenance of homeostasis; however, in contrast to
FBN9, FBN12 is downregulated during bacterial infections
[17,35]. This is consistent with a role of FBN12 as a negative
regulator of CEC1 expression.
Silencing AGAP009231 and AGAP009459 reduced PGN-in-
duced CEC1 transcriptional activation. AGAP009231 encodes a
transmembrane domain protein of the family of ninjurins, most
likely of the A sub-family, a complex class of cell adhesion
molecules that are proteolytically processed and shed by matrix
metalloproteases (MMP). MMP1 and NinjA genes are co-expressed
and upregulated in D. melanogaster S2 cells after LPS challenge [45]
and in adult flies after wounding [46]. Proteolytic cleavage of
NinjA by MMPs releases an ectodomain involved in cell adhesion
and cell-cell communication [47]. MMPs are known to play
various roles in inflammation and innate immunity but the identity
and function of their substrates and mechanisms are still to be
elucidated [48]. AGAP009231 has been previously shown to be
highly expressed and localized on the membrane of An. gambiae
circulating hemocytes [8]. Our data showing involvement of this
protein in AMP expression suggest an important role in mosquito
innate immunity, probably in signaling and cell communication.
As discussed earlier, AGAP009459 encodes the ortholog of
Drosophila cyclin-dependent protein kinase cdc2 that has been
implicated in several processes from cell cycle regulation to
cytoskeleton remodeling. Importantly, RNAi silencing of cdc2 also
leads to decreased STAT92E phosphorylation, suggesting a
regulatory role of cdc2 in JAK/STAT signaling [49]. The
involvement of JAK/STAT pathway in fruit fly hemocyte
differentiation and proliferation is well documented, but its exact
role in immune responses such as AMP expression remains
unclear [50]. In mosquitoes, the JAK/STAT pathway is activated
by immune challenges and is involved in responses against
pathogens [51,52,53], and our data suggest involvement of the
JAK/STAT pathway in CEC1 activation. The function of
AGAP009459 in phagocytosis of E. coli bioparticles may be related
to the involvement of cdc2 in cytoskeleton regulation, but could
also imply a novel role of JAK/STAT in phagocytosis.
Transcriptional regulation of the complement factor
LRIM1
We investigated the expression of the LRIM1 gene using an
approach identical to that described above for CEC1. LRIM1 is
expressed in An. gambiae hemocytes [8] and secreted in the
hemolymph in a disulfide-linked complex with the structurally
related protein APL1C; there the complex binds and solubilizes
TEP1cut, a cleaved, activated form of the complement C3-like
factor TEP1 [54,55]. This new complex plays a key role in
mosquito responses against invading malaria parasites. A previous
study showed that LRIM1 is transcriptionally induced following
PGN challenge [13]. We used a 1600 bp fragment of the LRIM1
promoter fused to luciferase (courtesy of M.J. Povelones). Our
preliminary data showed high luciferase activity in Sua5.1* cells
but no further upregulation following PGN challenge.
We investigated whether the lack of LRIM1 promoter upregula-
tion in Sua5.1* cells upon PGN challenge was due to inhibition by
other hemocyte factors (Figure 4 and Table S4). Our screen
identified four genes that inhibit transcriptional activation of the
LRIM1 promoter following PGN challenge, as silencing
AGAP009762, AGAP007499, AGAP003473 and AGAP001964 led
to increased luciferase expression compared to PBS control.
AGAP009762 is highly expressed in circulating hemocytes [8] and
encodes a EGF-like domain protein with similarities to Drosophila
phagocytosis receptors eater [56] and NimC1 [57] as well as to
other members of the Nimrod superfamily [58]. Interestingly, a
screen for novel regulators of JNK following IMD pathway
activation upon challenge with PGN in Drosophila cells, revealed
that the ortholog of AGAP009762 caused an increased P-JNK
protein expression, which, in turn, may act to modulate the
expression of Relish-controlled effectors [59].
AGAP007499 encodes a chloride channel protein, orthologous
to the human chloride channel 7. It is strongly expressed in
circulating hemocytes [8] and upregulated in mosquito cultured
cells after hydrogen peroxide treatment [13]. The Drosophila
ortholog of AGAP007499 is shown to play a role in the receptor
tyrosine kinase (RTK)-Ras-extracellular signal-regulated kinase
(MAPK/ERK) signaling pathway; its silencing leads to increased
MAPK phosphorylation following EGF stimulation [60]. It has
been previously shown that MAPK ERK signaling plays a role in
the mosquito immune response against malaria parasites [61].
AGAP003473 encodes a transmembrane protein with no signifi-
cant similarity to known proteins. Finally, AGAP001964 encodes a
previously uncharacterized member of the clip-domain serine
protease subfamily A (CLIPA) that lacks protease activity.
Importantly, several CLIPAs show Plasmodium infection pheno-
types [62,63], mostly by regulating the hemocyte-mediated
melanization reaction. Since LRIM1 is involved in malaria parasite
melanization and lysis, as well as in bacterial phagocytosis, we
hypothesize that the identified proteins function as negative
regulators of these reactions some of which (e.g. melanization) are
potentially costly to the host; thus LRIM1 is induced only when
these proteins are downregulated or presumably depleted during
these reactions.
Silencing AGAP001381 had an opposite effect, reducing
luciferase expression driven by the LRIM1 promoter 7 h after
challenge with PGN compared to mock PBS challenge. As
mentioned previously, AGAP001381 encodes the ortholog of the
fruit fly Laminin B1 and its silencing also increases phagocytosis of
E. coli bioparticles. These data conform to our hypothesis that a
network of negative and positive regulators is involved in induction
of LRIM1 expression that follows infection. Intriguingly, silencing
of Laminin B1 also resulted in a contrasting increase of the basal
LRIM1 promoter activity (Figure 4C), suggesting a dual role of
laminin B1 in activating and suppressing LRIM1 expression in the
presence and absence of immune challenge, respectively.
Two additional genes were identified as negative regulators of
LRIM1 basal expression: silencing of AGAP009119 and
AGAP002186 led to a significant increase of luciferase expression
driven by the LRIM1 promoter (Figure 4C). AGAP009119 encodes
a protein with tetratrico peptide structural repeats, involved in
protein-protein interactions, and a heat shock chaperonin-binding
motif, which is orthologous to the D. melanogaster Hsp70-interacting
protein 2 (HIP-replacement). AGAP002186 encodes a receptor of
lipophorin (Lp), that is the insect equivalent of low-density
lipoproteins and co-ortholog of the Drosophila LpR1 and LpR2
[64]. In An. gambiae, Apolipoprotein I and II, the main components
of Lp, have been shown to act antagonistically to TEP1-dependent
malaria parasite killing [65,66,67]. Interestingly, LpR2 (Lipo-
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phorin Receptor 2), the fruit fly ortholog of AGAP002186, has
been recently shown to suppress formation of melanotic tumors
[68].
Reduction of the basal LRIM1 promoter activity in cultured
cells was detected only after silencing REL2 compared to dsLacZ-
treated control cells, consistent with an earlier study showing that
REL2, as well as REL1, control basal LRIM1 and TEP1
expression [69].
Perspective: a complex regulatory network of the
hemocyte immune response
Our results identify 22 novel regulators of the hemocyte
immune response in this major African vector of human malaria.
As summarized in Figure 5 and in Table S5, a complex network of
positive and negative regulators of immediate (phagocytosis and
basal complement state) as well as induced (AMP expression and
induced complement state) responses are revealed.
Four membrane-bound or transmembrane proteins are impli-
cated in E. coli phagocytosis, but none of them have domains that
could indicate bona fide phagocytic receptors. Two of them, a
putative Ca2+ channel protein (AGAP000095) and a v-ATPase
(AGAP003879) have predicted functions that point to their
involvement in phagosome assembly and maturation. Of the
remaining two membrane-bound or transmembrane proteins,
AGAP004928 has an LPS-induced tumor necrosis factor alpha
factor domain and could be involved in immune signaling [33,34].
A very intriguing connection is revealed between phagocytosis
and regulation of the basal and induced expression of LRIM1, a
key component of the mosquito complement cascade [54,55] and
a known facilitator of E. coli phagocytosis [29]. The basement
membrane protein Laminin B1 inhibits both phagocytosis and
basal expression of LRIM1, but promotes LRIM1 expression after
immune challenge. Therefore, Laminin B1 appears to play a dual
role in maintaining the basal levels of complement in the
hemolymph and in promoting production of complement
components when needed or in preparation of potential reinfec-
tions. Whether this function of Laminin B1 is based on cell
signaling and hemocyte differentiation, it remains to be investi-
gated. Indeed, it has been suggested that immune priming of the
mosquito hemolymph by gut bacteria following midgut invasion
by malaria parasites causes hemocyte differentiation and attach-
ment to the midgut basement membrane (basal lamina), which
induces transient overexpression of LRIM1 and TEP1 [9].
Indeed complement is a very important defense reaction of the
mosquito hemolymph [16,29,70]. Upon TEP1 maturation cleav-
age, TEP1cut binds to the LRIM1/APL1C complex, where it
remains in an active soluble state until an infection occurs [54,55].
However, the last steps of TEP1 binding on the pathogen surface
remain unknown. Rono and co-workers [67] have recently
suggested that the observed antagonistic effect of Lp (and
Vitellogenin) on TEP1 binding on malaria parasites may be due
to Lp masking or competing for TEP1 binding sites on the parasite
surface, directly interacting with TEP1, or modifying the lipid
composition of the parasite membrane. Our finding that the Lp
receptor suppresses the basal expression of LRIM1 provides
additional insights into the mechanism underlying the effect of
Lp on TEP1-mediated parasite killing. Further investigation of the
roles of the Lp receptor, Laminin B1 and the additional regulators
of LRIM1 expression identified in this screen will shed light into
the regulatory mechanisms of mosquito complement and how
these impact upon infections with malaria parasites.
Materials and Methods
Mosquito rearing and dsRNA injections
An. gambiae G3 strain was maintained according to standard
insectary procedures (www.mr4.org/). DsRNA injections in 2-
days-old mosquitoes were performed as described previously [71].
Cell cultures mainteinance and RNAi
The An. gambiae cell lines 4a2, 4a3A, 4a3B, L3-5, SuaE.1,
SuaB.1, Sua4.0 and Sua5.1* were maintained as described (www.
mr4.org/ and [12]). Briefly, cells were grown in Schneider’s
medium supplemented with 10% fetal bovine serum (heat
inactivated), 100 U/ml Penicillin and 100 mg/ml Streptomycin
at 27uC. Splitting was carried out by shaking flasks to detach cells
and freezing/thawing procedures were performed according to
standard cell culture protocols. RNAi-mediated gene silencing of
cells was carried out in 96-well plates: approximately 105 cultured
cells were bathed in 1 mg dsRNA per well dissolved in serum-free
Schneider’s Medium and 2 h later complete medium was added to
obtain a final serum concentration of 10%.
Figure 5. Schematic representation of the role of identified regulators in the An. gambiae hemocyte immune response. A total of 22
positive (green) and negative (red) regulators are shown. Dotted lines indicate modulations of CEC1 and LRIM1 gene expression upon PGN challenge,
and solid lines describe the effect of genes on phagocytosis and basal expression of LRIM1.
doi:10.1371/journal.ppat.1003145.g005
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RNA preparation, dsRNA synthesis and Quantitative RT-PCR
Total RNA from wild type, KD females and cultured cells was
extracted using Trizol Reagent (Invitrogen). After DNAseI (Invitro-
gen) treatment, first strand cDNA was synthesized using oligo-d(T)
primers (Invitrogen) and Superscript Reverse Transcriptase II
(Invitrogen) according to the manufacturer’s instructions.
For dsRNA synthesis, T7-tailed primers (see Table S1) were
designed using the E-RNAi web-service at http://www.dkfz.de/
signaling/e-rnai3/evaluation.php. PCR products were synthesized
using cDNA from female mosquitoes as a template and purified
using the QIAquick PCR Purification kit (QIAGEN). DsRNA
synthesis was performed according to MEGAscript T7 Kit
(Ambion) manufacturer’s protocol and purification of dsRNA
was performed by phenol/chloroform extraction. The quality and
quantity of dsRNA were checked by agarose gel electrophoresis
and Nanodrop reading, respectively.
Quantitative RT-PCR was performed using the SYBR Green
PCR mastermix and analyzed using the ABI PRISM 7700
sequence detection system and the manufacturer’s instructions.
Expression levels were calculated by the relative standard curve
method using S7 as endogenous control [72,73]. Primers used are
listed in Table S1.
Viability assay
Cells were seeded in a 96-well plate at a concentration of 105
cells/well. The next day the medium was removed and cells were
treated with 1 mg dsRNA dissolved in 50 ml serum-free Schneider’s
Medium; 2 h later, complete medium was added to obtain a final
serum concentration of 10% in a volume of 100 ml. Four days after
dsRNA treatment, cells were stained with 1 mg/ml Hoechst 33342
(Invitrogen), and 500 nM Sytox Green (Invitrogen), by adding
25 ml of both chemicals to obtain a final volume of 150 ml/well.
After 30 min incubation in the dark at 28uC, plates were analyzed
by fluorescence microscopy. Images of cells were captured using a
Zeiss Axiovert 200 widefield fluorescence microscope (106
objective) and the Improvision Volocity Software. Three images
per well were taken (bright-field, DAPI and GFP). Images were
analyzed using a protocol developed in ImageJ. Briefly, images
were grouped in stacks and uniformly handled; stacks were
transformed into binary images, and cells labeled with Hoechst
and with Sytox Green were separately counted using Find
Maxima Process Tool. Numbers obtained were statistically
analyzed to quantify cell viability. ANOVA statistical analysis
followed by Bonferroni’s post-test were applied to groups of four to
six pictures per dsRNA treatment.
To assess cell size, stacks were further processed to subtract
background and enhance contrast and then transformed into
binary images; cells were converted into particles, and their
number, size and shape were calculated.
Viability assay was also performed using Cell Titer Blue kit
(Promega). Four days after dsRNA treatment carried out as above,
20 ml/well of CellTiter Blue solution were added to obtain a final
volume of 120 ml/well. Plates were incubated for 2 h and then
fluorescence produced by reduction of substrate resazurin into
resorufin was measured with BMG Labtech FLUOstar OMEGA
plate reader. Three replicates were performed and z-score analysis was
applied to identify positive phenotypes in each replicate. Thresholds of
+/22 were applied and positive candidates were considered those
passing the threshold in at least two out of three replicates.
Phagocytosis assay
Sua5.1* cells were seeded in 96-well plate at a concentration of
105 cells/well. The next day the medium was removed and cells
were treated with 1 mg dsRNA dissolved in 40 ml serum-free
Schneider’s Medium; 2 h later, complete medium was added to
obtain a final serum concentration of 10% in a volume of 50 ml.
PHRodo E. coli bioparticles (Invitrogen) were dissolved in sterile
1xPBS, sonicated according to manufacturer’s instructions and
50 ml were added in each well 3 days after gene silencing to obtain a
final volume of 100 ml/well. Cytochalasin D was added 20 min
before bioparticle challenge at a concentration of 10 mM or
100 mM. BMG Labtech FLUOstar OMEGA plate reader was
used to measure fluorescence intensity (Ex 532 nm/Em 595 nm
filter) immediately after pHRodo bioparticles challenge, and at
several time-points up to 24 h, keeping the temperature at 27uC
during the entire procedure. Three replicates were performed. Plate
reader outcomes were used to calculate z-score values for each
replicate. Hits were considered as those dsRNAs producing z-score
values above 2 or below 22 in at least two out of three replicates.
Numerical values were also pooled and statistically analyzed using
ANOVA followed by Tukey’s Multiple Comparison Test to assess
each dsRNA average value in relation to dsLacZ.
Automated fluorescence microscopy was also employed as a
separate method to assess fluorescent pHRodo bioparticles uptake
at 2 h and 20 h post challenge for those dsRNAs showing a
phenotype according to the microplate reader assay. Images were
captured using a Zeiss Axiovert 200 fluorescence widefield
microscopy and the Volocity Improvision software (106objective).
Image analysis and quantification were performed using a protocol
developed in ImageJ. Briefly, images were grouped in stacks and
uniformly handled; background was subtracted, contrast enhanced
and stacks were transformed into binary images to separate the
fluorescent particles from the cell layer and quantify the spot
number and size. Numbers obtained from at least two experiments
were statistically analyzed using GraphPad Prism software.
Numbers were converted to percent values compared to dsLacZ.
After normality test, values of each dsRNA were compared to
dsLacZ using student’s t-test.
In vivo phagocytosis assays were performed on 2-day old
mosquitoes injected with dsRNA as described above. Four days
later, mosquitoes were injected again in the thorax with 69 nl of
pHRodo E. coli bioparticles and allowed to recover and resume
phagocytosis for 1 h. Mosquitoes were partially dissected (wings
and legs removed) and gently compressed between a slide and a
coverslip (using clay to hold them together) for imaging. Images of
mosquito abdomens were captured using a Zeiss Axiovert 200
widefield fluorescence microscope and the Volocity Improvision
software. At least two replicates for each dsRNA treatment were
carried out, and at least 8 mosquitoes per KD were analyzed by
microscopy with no less than four pictures captured per mosquito.
Fluorescence images of sections of mosquito abdomens were
captured as described above and shown in Figure 3 (106
objective). Quantification and statistical analysis were carried out
as described above for pHRodo bioparticle phagocytosis in
cultured cells.
Luciferase assay
Sua5.1* cells were seeded in a 96-well plate at a concentration
of 105 cells per well. Upon reaching 80% confluence, the medium
was removed and cells were treated with 1 mg dsRNA dissolved in
40 ml serum-free Schneider’s Medium. Two h later, complete
medium was added to obtain a final serum concentration of 10%
in a volume of 60 ml. Four days after dsRNA treatment, cells were
washed and co-transfected in 50 ml of final volume with CEC1 or
LRIM1 promoter firefly luciferace fusion reporter constructs
(Promega pGL3 backbone) and reference pAct5C-Renilla lucifer-
ase construct using Effectene Transfection Reagent (QIAGEN)
following the manufacturer’s instructions. One day after transfec-
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tion, 25 ml of PGN (Sigma) were added to obtain a final
concentration of 100 mg/ml. Seven h later, cells were subjected
to Dual Luciferase assay (Promega) according to the manufactur-
er’s instructions in a final volume of 150 ml per well. Relative light
units per second for both firefly and renilla luciferase were
measured using the Luminometer mode of BMG Labtech
FLUOstar OMEGA plate reader. RLU measurements were
obtained dividing the firefly by renilla measurements. RLUs from
three replicates were averaged and z-scores calculated after PGN
and PBS treatments. One-way ANOVA followed by Dunnet’s
multiple-comparison post-test was also performed to compare
dsLacZ control and dsRNA RLUs.
Data analysis
Z-score was calculated using the formula zkj = (ykj2M)/S, where
ykj is the background subtracted value for the k
th well in the jth
replicate, and M and S are mean and standard deviation (SD) of
the distribution of y values, respectively [74]. We considered
positive hits those dsRNAs exhibiting z-scores.2 or ,22, which
corresponds to SDs above or below the population mean in a
given replicate. Considering that the critical z-score values when
using a 95% confidence level are 21.96 and +1.96 SDs, positive
hits have corresponding p values,0.05. To assess z-score
correlation between replicates, D’Agostino & Pearson omnibus
normality test was applied to examine whether the data follow a
Gaussian distribution. Correlations were computed using Spear-
man r correlation test for not normally distributed data and
Pearson r correlation test for normally distributed data. GraphPad
Prism 5 software was used for statistical analyses and graph design.
Supporting Information
Dataset S1 dsRNA hemocyte-specific library. The main
features of dsRNAs and target genes used in this study are
presented. DsRNA IDs, KD phenotypes in RNAi screens,
VectorBase gene IDs, Affymetrix probe codes and previous
ENSEMBL IDs are listed in columns A, B, C, D and E,
respectively. Circulating hemocyte microarray information from
[8] are summarized in columns F (cluster), G (normalized
hemocyte value), H (normalized carcass value) and I (normalized
head value). Comments (name and/or homology of An. gambiae
genes) and IPRO domain data are reported in columns J and K,
respectively. D. melanogaster orthologs are shown in column L, and
corresponding FlyBase IDs in column M. D. melanogaster KD
phenotypes according to the GenomeRNAi database are reported
in column N. For further details see Text S1.
(XLS)
Figure S1 Quantitative analysis of viability assays. (A)
Images of L3–5 confluent cell layers after dsRNA treatments as
indicated on the left side of each figure. Nuclei are stained with
Hoechst, and dead cells are stained with Sytox Green. (B) Viability
assay analysis of 8 An. gambiae cell lines treated with dsRNAs
targeting IAP1, AGAP005160 and AGAP008001. Total number of
cells (Hoechst) and dead cells (Sytox Green) were counted by
image analysis using a protocol developed in ImageJ. Ratios of
dead and total number of cells are reported in the graphs. Three
pictures taken from two independent replicates were analyzed, and
averages and standard errors are shown. One-way ANOVA
followed by Bonferroni’s Multiple Comparison Test was applied
(*, p,0,05; **, p,0,01; ***, p,0,001). (C) Kaplan-Meier survival
curves of adult mosquitoes following injection with dsRNA
targeting IAP1 and AGAP008001. Percent survival compared to
dsLacZ treated controls is shown.
(TIF)
Figure S2 Qualitative analysis of viability assays. (A)
Nuclear staining with Hoechst of Sua4.0 cultured cells that are
either untreated (no dsRNA) or treated with dsRNA targeting
LacZ (dsLacZ) and AGAP005160 (ds5160). Note that after ds5160
treatment, cells showed impaired cytokinesis and increased nuclear
size. (B) Quantification of the number of cells by counts of Hoechst
positive nuclei and (C) measurements of nuclear size, using a
protocol developed in ImageJ. Pictures taken from three
independent replicates were analyzed. Mean values and standard
errors are shown. One-way ANOVA followed by Tukey’s Multiple
Comparison Test was used for statistical analyses (*, p,0,05; ***,
p,0,001).
(TIF)
Figure S3 Z-score correlation between replicates in
viability assays. D’Agostino & Pearson omnibus normality test
revealed that data do not fit a normal distribution. Therefore,
correlation between z-score values of replicates I, II and III was
calculated using Spearman r correlation test. Correlation coeffi-
cients (r) are indicated. Positive hits (z-scores.2 or ,22 in at least
two of three replicates) are shown as open circles. Control no
dsRNA-treated samples and samples treated with 100 mM H2O2
are also shown.
(TIF)
Figure S4 Phagocytosis assay. (A) Sua5.1* cells treated with
dsLacZ, dsCactus and dsBINT2 were challenged with E. coli and
Staphylococcus aureus pHRodo bioparticles and the levels of
phagocytosis were measured 1 h later by microtiter plate reading.
Values were background subtracted. (B) Sua5.1* cells were treated
with Cytochalasin D at concentrations of 10 mM and 100 mM in
conditioned medium and then challenged with pHRodo E. coli.
The levels of phagocytosis were measured at different time points
(TP) as indicated. Values were background subtracted. (C) Z-score
plots relative to microplate reader measurements of E. coli
pHRodo conjugated bioparticles uptake at different TPs. Each
dsRNA was screened in triplicate and positive hits were considered
as those dsRNAs with z-score in at least 2 out of the 3 replicates
.2 (red) or ,22 (green). 0 h TP (immediately after bioparticle
challenge) was subtracted in the graphs TP 1-0, TP 3-0, TP 6-0
and TP 24-0 (measurements at 1 h, 3 h, 6 h and 24 h,
respectively). Z-scores at TP 1, 3 and 6 (1, 3 and 6 h after
challenge, without subtracting the TP 0 h, respectively) are shown,
as well as z-score plots indicating the kinetic of the uptake between
1 h and 3 h after challenge (TP 3-1). (D) Correlation between z-
score values of different replicates. TPs selected are indicated on
top of each graph, and replicates compared are specified at the left
of each graph. Correlation coefficients (r) are also indicated.
(TIF)
Figure S5 Gene-specific KD efficiency in cell cultures
(A–D) and mosquitoes (E). Confluent Sua5.1* cells were
incubated with dsRNAs targeting AGAP004016 (A),
AGAP004928 (B), AGAP005227 (C) and AGAP009201 (D), and
4 days later the expression of targeted genes was analyzed by qRT-
PCR. Data were normalized to S7 and calibrated to the gene-
specific expression in dsLacZ treated samples. Three wells for each
KD were analyzed. The level of silencing of three of these genes in
mosquitoes was also tested (E). dsRNAs targeting AGAP004928,
AGAP005227, AGAP009201 and against LacZ were injected into
2-day old female mosquitoes and the expression of silenced genes
was measured by qRT-PCR 4 days after dsRNA treatments. Data
were normalized to S7 levels and calibrated to the gene-specific
expression in dsLacZ treated mosquitoes.
(TIF)
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Table S1 List of primers used in this study. Name of
dsRNA (#), AGAP code (ID), T7-tailed primers code (Primer
Forward and Primer Reverse), and relative sequences are
reported. Primers for Q-PCR (QF and QR) are listed at the
bottom of the table.
(DOC)
Table S2 Genes exploited as controls in viability assays.
Name of dsRNA (#), AGAP code (IDs), gene name, IPRO ID and
length of T7 dsRNA products are reported.
(DOC)
Table S3 Phagocytosis assay results. Datasets from in vitro
measurements using microplate reader were statistically analysed
employing two statistical approaches, z-score threshold and
ANOVA calculation. In column ‘‘#’’ are listed dsRNA labels;
AGAP ID number and IPRO domain descriptions are reported in
the next two columns. ‘‘Z-score’’ column lists genes with
significant values at the indicated TP (for at least two replicates
out of three) from plate reader measurements. Microplate reader
values were also averaged and compared to dsLacZ control values:
positive hits for each TP, according to ANOVA statistical analysis
followed by Tukey’s Multiple Comparison Test, are listed in
‘‘ANOVA P,0,05’’ column. 8 genes selected from these 13
significant candidates were evaluated in in vivo assay. The ‘‘in vivo
% TP2’’ column reports the percent of phagocytosis as calculated
by imaging analysis in in vivo experiments 2 h after challenge. SP,
Signal Peptide; TD, transmembrane domain; ns, not significant;
nd, not determined.
(DOC)
Table S4 Luciferase assay results. Gene knockdowns (KD)
that modulate the regulation of CEC and LRIM1 promoters upon
PGN challenge according to the z-score analysis are shown; KDs
modulating basal LRIM1 promoter activity (PBS challenge) are
also summarized; IPRO domains short descriptions are reported.
SP, Signal peptide; TD, transmembrane domain.
(DOC)
Table S5 Summary of RNAi screens results. In column
‘‘#’’ are listed dsRNA labels; AGAP ID number and IPRO
domain descriptions and homologies are reported in the next 2
columns. KD phenotypes of genes that gave a positive phenotype
in at least one of the 4 assays are summarized in the next 4
columns.
(DOC)
Text S1 Additional information and data on viability
assay, ex vivo phagocytosis assay, knockdown efficiency
assessment and Drosophila melanogaster orthologs.
(DOC)
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